I guess Mr. Hunt isn't too familiar with Florida statutes,

New Post Public Reply Private Reply Replies (2) Message Board
hedge_fun wlfr01 #1864
I guess Mr. Hunt isn't too familiar with Florida statutes, and especially those concerning civil actions for libel. At least he doesn't appear to understand his next proper move. Nor do you seem to understand yours.....as a shareholder.

Quote:
I am also a shareholder of SFRX. I also believe you have harmed the company and you should be held accountable.


SFRX has the opportunity until 5 pm tomorrow to provide proof that the documents I have which were provided by Mary are not the application or permit issued. It is those documents that are the basis for my statements.

Under Florida law, SFRX will have to prove the statements I made were false and I intentionally posted them knowing they were false before they can collect any damages.

Further, SFRX's other attorney whose last name also starts with Hu like Hunt (Huffman) suggested I was harming the company last summer.

So why has Kyle waited so long to act? If I was harming the company last year, why have they not acted yet? To date they have simply threatened action.

But I am damaging the company? And it's in the MILLIONS of dollars? What are they waiting on?

I am required to file a correction under Florida law for any false statements I have made, but I need to see the "3 item" and 80/20 agreement in order to make such a correction. For some reason Kyle hasn't provided it, but he says I am damaging the company.

Further, Sinclair is required to report what you say he confirmed to the FBAR. I also need to see that documentation in order to correct the record.

At this point it's Kyle's move. But anyone could provide proof and I would apologize and make needed corrections. I have opened the floor up to anyone.

Simply saying it isn't true, or saying Sinclair said he confirmed what was filed with the Court isn't good enough.

Here's the basis of the four items I mentioned.

Application: https://www.scribd.com/doc/299332582/2014-05-...on-Area-A2

Permit: https://www.scribd.com/doc/298727048/2014-07-...t-EXECUTED

Please note: I will refer to Huffman as Hu1, and Hunt as Hu2 going forward. It will save storage space on computers.

But if you thought I was damaging the company, and you knew there was a "3 item" and/or an 80/20 agreement, where is it stated or implied in the permit that was issued?

And when did Sinclair report his "alleged" findings to the FBAR?

Seafarer Exploration (SFRX) Stock Research Links

SFRX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 28

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 34

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 36

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 62

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 47

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 45

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Mixed Markets: Analyzing Germany's Stock Performance

Updated Category News Views 211

Markets in Germany Prepare for Fluctuations As trading wrapped up on Wednesday, the German stock market exhibited a mixed bag of results. While certain sectors, such as Food & Beverages, Media, and Financial Services, reported gains, others faced setbacks. The Consumer & Cyclical, Construction, and Pharmaceuticals & Healthcare sectors saw declines, reflecting the market's...

Continue Reading
Teradyne's Q3 Earnings: Strong Performance and Future Growth Potential

Updated Category News Views 176

Teradyne's Q3 Earnings Exceed Expectations Teradyne Incorporated (NASDAQ: TER), a prominent player in automated test equipment, has released its third-quarter results, building a narrative of success and optimism. The company reported impressive sales figures of $737 million, with non-GAAP earnings per share (EPS) reaching $0.90, bolstered by a solid gross margin of...

Continue Reading
So-Young Plans to Revise ADS Ratio for Improved Trading

Updated Category News Views 163

So-Young's Strategic Shift in ADS Ratio So-Young International Inc. (NASDAQ: SY), a leading aesthetic treatment platform, has recently announced plans to change the ratio of its American depositary shares (ADSs) to Class A ordinary shares. This strategic decision aims to refine its trading dynamics, enhancing value for its shareholders. Details of the ADS Ratio Change The...

Continue Reading
Understanding Recent Developments at GitLab: Investor Insights

Updated Category News Views 78

Contextual Overview of GitLab's Recent Investor Challenges In a rapidly evolving technological landscape, GitLab Inc. stands at a critical juncture as investors navigate its latest developments and challenges. Recent announcements regarding financial performance have sparked interest and concern among stakeholders. Understanding the implications of these changes is...

Continue Reading
Celebrating 15 Years of Transformative Care at Senderra Pharmacy

Updated Category News Views 273

15 Years of Innovation in Specialty Pharmacy Senderra Specialty Pharmacy has proudly reached a remarkable milestone—15 years of providing top-tier healthcare solutions in the specialty pharmacy sector. This anniversary embodies a journey marked by significant advancements and unwavering commitment to revolutionizing patient care. Transforming Patient Experiences Since...

Continue Reading